Outsourcing

Articles

Catalent’s Singapore facility is awarded GMP certification.

Catalent expands packaging capabilities in Singapore

Vetter completes on-site expansion activities of visual inspection and in-process control at Chicago facility.

Vetter Completes Expansion at Chicago Facility

Pharmaceutical companies should take into consideration intellectual property protection when outsourcing the packaging of their products.

Protecting Intellectual Property in Packaging

CDMO Vetter produces identifiable labeling for a top-ten pharmaceutical company.

Vetter Serializes First Product for South Korea

The company has increased capacity for cold storage and controlled drug substances handling at its European facilities.

Catalent Expands Clinical Packaging Capabilities in Europe

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Careful selection of a contract packager should include interviews, surveys, and on-site visits.

Choosing a Contract Packager

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

There are significant differences between small molecules and biologics fill/finish capacity.

Fill/Finish Capacity Use for Biologics

Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.

New Packaging Technologies Displayed at INTERPHEX

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.

Contract Packaging, Logistics, and Distribution